The Middle East Institute of Health Oncology team, composed of surgeons and medical oncologists, is specialized and dedicated to detect and treat cancer.
The center is equipped with cutting-edge technology:
·Regional Hyperthermic chemotherapy including Intraperitoneal Hyperthermic chemotherapy,
·Limb perfusion for melanoma and sarcoma,
·Hepatic perfusion (unique in the Middle East),
·Sentinel lymph node biopsy,
·Radiofrequency ablation (Non-surgical treatment for cancer)
Surgical Oncology department:
1.Senology Program “Women Health Center”
A group of specialized physicians, nurses and trained personnel dedicated to the management of diseases of the breast.
5.Cytoreductive surgery with Hyperthermic Intraperitoneal Chemotherapy program (CRS + HIPEC). Peritoneal metastases (PM) are an end-stage presentation of multiple malignancies. It has a dismal prognosis. The standard treatment of PM is systemic chemotherapy which has a limited benefit. Recently peritoneal metastasis is considered by many as an advanced locoregional disease and a new treatment is offered for this lethal condition.
The treatment consists of two parts:
–A surgical procedure that treats the macroscopic disease in the abdomen and pelvis.
–An intraoperative heated chemotherapy delivered by a dedicated machine to treat the residual microscopic disease.
*Both interventions are given in one surgical procedure.